FDA Funds Pediatric Trial Testing Reprogrammed HSV to Treat Cancer

A clinical trial testing a genetically reprogrammed herpes simplex virus as treatment for deadly forms of childhood cancer has received a U.S. Food and Drug Administration grant to support the research.
FirstScience